F. Hoffmann-La Roche has patented a method for generating a module to determine analyte concentration in body fluid samples. The method involves using image data from test strips, recorded by various devices, to train a neural network model for accurate analysis. The system and method aim to improve analyte concentration determination in bodily fluids. GlobalData’s report on F. Hoffmann-La Roche gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on F. Hoffmann-La Roche, Cancer treatment biomarkers was a key innovation area identified from patents. F. Hoffmann-La Roche's grant share as of February 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Method for generating module to determine analyte concentration in body fluid
A recently granted patent (Publication Number: US11928814B2) discloses a method for generating a module that can determine the concentration of an analyte in a sample of body fluid. The method involves providing a set of measurement data derived from images of test strips, recording color transformations in response to applying body fluid containing the analyte. A neural network model is generated through machine learning using this data, and a software-implemented module with an analyzing algorithm is created to determine analyte concentration in subsequent samples. The module analyzes color information from images of test strips to provide concentration data for the analyte in the sample.
Furthermore, the patent describes a system for generating and utilizing the module to determine analyte concentration in body fluid samples. The system includes data processors that provide measurement data, generate a neural network model through machine learning, and create a module with an analyzing algorithm. This module can then be used to determine analyte concentration in a present sample by analyzing color information from images of test strips. The patent also includes a method for generating the module, involving obtaining images of test strips using mobile devices, constructing and training a neural network model based on the image data, and generating a module capable of determining analyte concentration in body fluid samples.
To know more about GlobalData’s detailed insights on F. Hoffmann-La Roche, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.